Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis

I.J. van den Elskamp, B.H. Boden, V. Dattola, D.L. Knol, M. Filippi, L. Kappos, F. Fazekas, K. Wagner, C. Pohl, R. Sandbrink, C.H. Polman, B.M.J. Uitdehaag, F. Barkhof

Research output: Contribution to journalArticleAcademicpeer-review

41 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)875-881
JournalNeuroradiology
Volume52
Issue number10
DOIs
Publication statusPublished - 2010

Cite this

van den Elskamp, I. J., Boden, B. H., Dattola, V., Knol, D. L., Filippi, M., Kappos, L., ... Barkhof, F. (2010). Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis. Neuroradiology, 52(10), 875-881. https://doi.org/10.1007/s00234-009-0645-1